We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

HAIR LOSS TREATMENT MARKET ANALYSIS

Hair Loss Treatment Market, By Product Type (Corticosteroids, Antihypertensive, Topical Immune-modulators, Others), By Type (Noncicatricial (Telogen Effluvium, Androgenetic Alopecia, Alopecia Areata), Cicatricial, Others), By Route of Administration (Oral, Topical), By Gender (Male, Female ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Oct 2023
  • Code : CMI4374
  • Pages :180
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Challenges And Opportunities

Global Hair Loss Treatment Market – Drivers

  • Increasing incidence of alopecia and other disease that leads to hair loss: Increasing prevalence of diseases such as telogen effluvium, androgenetic alopecia, alopecia areata, and others is expected to boost demand for hair loss treatment, thus, propelling the market growth over the forecast period. For instance, on July 23, 2023, according to an article published by the U.S. Department of Health and Human Services, more than 50 Mn men and 30 Mn women are estimated to be affected by androgenetic alopecia in U.S. each year
  • Increasing research and development activities by key market players: Key market players are focusing on adoption of research and development activities for treatment of hair loss diseases such as alopecia areata, and this is expected to drive the market growth over the forecast period. For instance, Concert Pharmaceuticals, a subsidiary of Sun Pharmaceutical Industries Pvt. Ltd., a India-based global pharmaceutical company, has its drug candidate CTP-543 is in phase-III of clinical trial. The CTP-543 is been tested for a treatment solution for alopecia areata.

Global Hair Loss Treatment Market: Restraint

  • Side effect and safety concerns associated with hair loss treatment drugs: The factor such as side effects and safety concerns associated with alopecia treatments can hamper the market growth. Medications like minoxidil and finasteride that arecommonly used for hair loss can cause scalp irritation or other adverse reactions in certain individuals. These potential side effects raise safety concerns and may discourage individuals from pursuing treatment or continuing the use. As a result, the key market players should focus on research and development so that new products are available with solutions having limited side effects.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.